ABBEY HEARING CLINICS LTD

💤Zombieactive
07288832 · ltd · incorporated 2010-06-18
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Jun 2025
Net worth
£13.1k
book net assets
Opportunity
77/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: SIC 47741
Sector: Wholesale & retail
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 77/100 (strong), bankability 85/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).

🏦

Refinance opportunity

1 live charge · oldest 10.4y

45/100
under pressure

Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.

  • · Oldest live charge is 10.4 years old — likely at or near maturity.
  • · Single lender — cleanest path to refinance.
  • · Distress signals active — lender appetite narrows.

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
1 charges (1/1 with lender, 1/1 with type)
90
Directors & officers
2 officers (1 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
50 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
77/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
60
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £13,116

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£13k
↑ 198% YoY
Current Assets
£115k
↓ 18% YoY
Current Liabilities
£0£28k£56k£84k£112k£140kJun 2024Jun 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-06-302024-06-30
Total assets£73.3k£78.5k
Current assets£114.8k£139.5k
Net assets£13.1k£4.4k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 accounts
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (23 events)Click to expand
  1. 2026-03-31
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-03-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2024-03-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  4. 2023-03-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  5. 2022-03-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2021-05-06
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  7. 2021-05-06
    📄
    change-person-director-company-with-change-date
    officers · CH01
  8. 2021-05-06
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  9. 2021-03-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2020-10-16
    📄
    mortgage-satisfy-charge-full
    mortgage · MR04
  11. 2020-10-16
    🔓
    Charge satisfied #1
  12. 2020-03-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  13. 2019-07-02
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  14. 2019-03-27
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  15. 2018-03-29
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  16. 2018-03-15
    📄
    change-person-director-company-with-change-date
    officers · CH01
  17. 2018-03-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  18. 2018-01-11
    📄
    change-person-director-company-with-change-date
    officers · CH01
  19. 2015-12-23
    🔒
    Charge registered #1
    Lender: Starkey Laboratories Limited
  20. 2015-06-01
    HARRIS, Karen Jane resigned
    director
  21. 2010-06-18
    🏢
    Company incorporated
    As ABBEY HEARING CLINICS LTD
  22. 2010-06-18
    HARRIS, Charles William Luke appointed
    director
  23. 2010-06-18
    HARRIS, Karen Jane appointed
    director

Owner dependency

85/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.

Succession & seller-readiness

68/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • secondary12+ year tenure: Director in role 16 years.
  • secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mrs Karen Jane Harris
Individual · British · DOB 10/1974 · age 52
2550%
25–50%board control25-50% shares · 25-50% voting · board control06/04/2016
Mr Charles William Luke Harris
Individual · British · DOB 12/1974 · age 52
2550%
25–50%board control25-50% shares · 25-50% voting · board control06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Retail · DT postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
109 WETSUITS LTD
13743325 · est 2021 · no financials extracted
4y
1855 LIMITED
14125070 · est 2022 · no financials extracted
3y
1NEXUS LTD
15842203 · est 2024 · no financials extracted
1y
20TH CENTURY DESIGN LTD
11917582 · est 2019 · no financials extracted
7y
5 STAR BODY JEWELLERY LIMITED
05169830 · est 2004 · no financials extracted
21y
A & K READ LIMITED
07936813 · est 2012 · no financials extracted
14y
AARINKAN LTD
17071434 · est 2026 · no financials extracted
ABBEY PHARMACY (SHERBORNE) LIMITED
04291981 · est 2001 · no financials extracted
24y
ABBOTSBURY HOLDINGS LTD
14710460 · est 2023 · no financials extracted
3y
ABC DESIGN & MOJI UK LTD
15182937 · est 2023 · no financials extracted
2y
ABOCH 100 LTD
16863318 · est 2025 · no financials extracted
ACTIVE MOBILITY VEHICLES LIMITED
03286373 · est 1996 · no financials extracted
29y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2010-06-18
Jurisdictionengland-wales
Primary SIC47741 — SIC 47741

Registered office

24 Cornwall Road
Dorchester
Dorset
DT1 1RX
England

Filing status

Accounts
Next due: 2027-03-31
Last made up to: 2025-06-30
Confirmation statement
Next due: 2026-07-02
Last: 2025-06-18

Officers (1 active · 1 resigned)

HARRIS, Charles William Luke
director · ~52y · appointed 2010-06-18
View their other companies + combined net worth →
Active
HARRIS, Karen Jane
director · ~52y · appointed 2010-06-18 · resigned 2015-06-01
Resigned

Click a director name to see their full track record across all companies.

Mortgages & charges

1
Total charges
0
Outstanding
0
Active lenders
Status:Lender:1 of 1 shown
TypeProperties
satisfied
Starkey Laboratories
Starkey Laboratories Limited
A registered charge23/12/201516/10/2020

Recent filings (50 total)

accounts-with-accounts-type-micro-entity
accounts · AA
2026-03-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-06-19
accounts-with-accounts-type-micro-entity
accounts · AA
2025-03-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-06-18
accounts-with-accounts-type-micro-entity
accounts · AA
2024-03-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-06-19
accounts-with-accounts-type-micro-entity
accounts · AA
2023-03-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-06-20
accounts-with-accounts-type-micro-entity
accounts · AA
2022-03-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-06-18
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2021-05-06
change-person-director-company-with-change-date
officers · CH01
2021-05-06
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2021-05-06
accounts-with-accounts-type-micro-entity
accounts · AA
2021-03-30
mortgage-satisfy-charge-full
mortgage · MR04
2020-10-16